DK0593513T3 - Tryptaminanaloger, deres syntese og deres anvendelse som 5-HT,-lignende eller 5-HT2-receptoragonister - Google Patents

Tryptaminanaloger, deres syntese og deres anvendelse som 5-HT,-lignende eller 5-HT2-receptoragonister

Info

Publication number
DK0593513T3
DK0593513T3 DK92912269T DK92912269T DK0593513T3 DK 0593513 T3 DK0593513 T3 DK 0593513T3 DK 92912269 T DK92912269 T DK 92912269T DK 92912269 T DK92912269 T DK 92912269T DK 0593513 T3 DK0593513 T3 DK 0593513T3
Authority
DK
Denmark
Prior art keywords
pct
date
synthesis
receptor agonists
sec
Prior art date
Application number
DK92912269T
Other languages
Danish (da)
English (en)
Inventor
Lawrence Ivan C O Smithk Kruse
Rodney Christopher Young
Alberto Julio Kaumann
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919113382A external-priority patent/GB9113382D0/en
Priority claimed from GB919113385A external-priority patent/GB9113385D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK0593513T3 publication Critical patent/DK0593513T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92912269T 1991-06-21 1992-06-17 Tryptaminanaloger, deres syntese og deres anvendelse som 5-HT,-lignende eller 5-HT2-receptoragonister DK0593513T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919113382A GB9113382D0 (en) 1991-06-21 1991-06-21 Compounds
GB919113385A GB9113385D0 (en) 1991-06-21 1991-06-21 Compounds
PCT/GB1992/001089 WO1993000333A1 (en) 1991-06-21 1992-06-17 Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists

Publications (1)

Publication Number Publication Date
DK0593513T3 true DK0593513T3 (da) 1999-07-05

Family

ID=26299103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912269T DK0593513T3 (da) 1991-06-21 1992-06-17 Tryptaminanaloger, deres syntese og deres anvendelse som 5-HT,-lignende eller 5-HT2-receptoragonister

Country Status (13)

Country Link
US (1) US5571833A (cs)
EP (1) EP0593513B1 (cs)
JP (1) JPH06508354A (cs)
AT (1) ATE172723T1 (cs)
AU (1) AU1928892A (cs)
CA (1) CA2110574A1 (cs)
DE (1) DE69227458T2 (cs)
DK (1) DK0593513T3 (cs)
IE (1) IE921993A1 (cs)
MX (1) MX9203050A (cs)
PT (1) PT100603A (cs)
TW (1) TW217407B (cs)
WO (1) WO1993000333A1 (cs)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226532D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5496957A (en) * 1993-09-01 1996-03-05 Virginia Commonwealth University Tryptamine analogs with 5-HT1D selectivity
EP0666847B1 (en) * 1993-09-01 1998-06-17 Allelix Biopharmaceuticals Inc. Tryptamine analogs with 5-ht1d selectivity
US5504101A (en) * 1994-05-06 1996-04-02 Allelix Biopharmaceuticals, Inc. 5-HT-1D receptor ligands
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6664286B1 (en) 1998-09-18 2003-12-16 Alcon Manufacturing, Ltd. Serotonergic 5ht2 agonists for treating glaucoma
EP1132389A1 (en) * 2000-03-06 2001-09-12 Vernalis Research Limited New aza-indolyl derivatives for the treatment of obesity
US6956036B1 (en) 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6806285B1 (en) 2000-03-17 2004-10-19 Alcon, Inc. 5-Hydroxyl indole derivatives for treating glaucoma
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
WO2001070686A1 (en) * 2000-03-17 2001-09-27 Alcon, Inc. 5-hydroxy indole derivatives for treating glaucoma
US7005443B1 (en) * 2000-03-17 2006-02-28 Alcon, Inc. 5-Hydroxy indazole derivatives for treating glaucoma
AU2001219185A1 (en) 2000-03-17 2001-10-03 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
WO2004098807A1 (en) * 2000-11-21 2004-11-18 Barsplice Products, Inc. Method of making steel couplers for joining concrete reinforcing bars
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
WO2002098400A1 (en) * 2001-06-01 2002-12-12 Alcon, Inc. Novel arylaminopropane analogues and their use for the treatment of glaucoma
PL366636A1 (en) * 2001-06-01 2005-02-07 Alcon, Inc. Pyranoindazoles and their use for the treatment of glaucoma
CA2447156A1 (en) * 2001-06-01 2002-12-12 Alcon, Inc. Novel fused indazoles and indoles and their use for the treatment of glaucoma
US6884816B2 (en) * 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
WO2003051291A2 (en) * 2001-12-14 2003-06-26 Alcon, Inc. Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
BR0314419A (pt) * 2002-08-30 2005-07-19 Alcon Inc Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o
RU2227140C1 (ru) * 2002-10-22 2004-04-20 Закрытое Акционерное Общество "Лорр" Способ получения серотонина и его фармакологических солей
BR0316775A (pt) * 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
EP1572647B1 (en) 2002-12-20 2016-09-21 Basf Se Synthesis of amines and intermediates for the synthesis thereof
WO2005053688A1 (en) * 2003-11-26 2005-06-16 Alcon, Inc. Substituted furo[2,3-g] indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) * 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
WO2005058911A2 (en) * 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
US7425572B2 (en) * 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
JP5868980B2 (ja) * 2010-09-14 2016-02-24 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ トリプタミン誘導体、その製造方法および胃疾患についての使用
US20200078335A1 (en) * 2017-05-01 2020-03-12 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods to reduce pathogenesis
GB201907871D0 (en) 2019-06-03 2019-07-17 Small Pharma Ltd Therapeutic compositions
HUE061482T2 (hu) * 2019-11-07 2023-07-28 Small Pharma Ltd Szintézismódszer
US11773062B2 (en) 2021-03-22 2023-10-03 Small Pharma Ltd Deuterated compounds
AU2021338384A1 (en) * 2020-09-04 2023-03-30 Gilgamesh Pharmaceuticals, Inc. Azetidinyl tryptamines and methods of treating psychiatric disorders
US11660289B2 (en) 2020-12-01 2023-05-30 Small Pharma Ltd. Deuterated or partially deuterated N,N-dimethyltryptamine compounds
EP4271682A4 (en) * 2020-12-31 2025-03-12 1280225 B.C. Ltd. Method of synthesizing indole compounds
EP4377293A4 (en) * 2021-07-26 2025-06-25 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College COMPOUNDS AND METHODS FOR THE TREATMENT OF 5-HT2-RESPONSIBLE DISEASES
US11697638B2 (en) 2021-09-08 2023-07-11 Small Pharma Ltd 5-methoxy-N,N-dimethyltryptamine crystalline forms
WO2024138007A2 (en) * 2022-12-21 2024-06-27 Caamtech, Inc. Tryptamine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5883671A (ja) * 1981-11-11 1983-05-19 Mitsui Toatsu Chem Inc トリプタミン誘導体の製造法
AU4649189A (en) * 1988-11-14 1990-06-12 Upjohn Company, The Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents

Also Published As

Publication number Publication date
EP0593513B1 (en) 1998-10-28
EP0593513A1 (en) 1994-04-27
AU1928892A (en) 1993-01-25
TW217407B (cs) 1993-12-11
PT100603A (pt) 1993-08-31
US5571833A (en) 1996-11-05
IE921993A1 (en) 1992-12-30
ATE172723T1 (de) 1998-11-15
MX9203050A (es) 1993-07-01
DE69227458T2 (de) 1999-04-29
JPH06508354A (ja) 1994-09-22
DE69227458D1 (de) 1998-12-03
CA2110574A1 (en) 1993-01-07
WO1993000333A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DK0593513T3 (da) Tryptaminanaloger, deres syntese og deres anvendelse som 5-HT,-lignende eller 5-HT2-receptoragonister
DK0687268T3 (da) Spiroazacykliske derivater som substans P-antagonister
FI954944A0 (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon
DK0687251T3 (da) 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister
NO20021751L (no) Purinderivater
BG106569A (en) Purine derivatives
DK31092D0 (da) 2-pyrimidinyl-1-piperazin-derivater, deres fremstilling og anvendelse
BG106289A (en) Purine derivatives
DE69132141D1 (de) Neuroprotective indolone und verwandte derivate
MY132229A (en) Indole derivatives as 5-ht receptor antagonist
CO4910163A1 (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ATE331726T1 (de) Adenine-derivate
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
EP0354777A3 (en) 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives
NO943261D0 (no) Indolderivater som 5-HT, agonister
DE60317333D1 (de) Tetracyklische arylsulfonylindole mit affinität zum serotonin rezeptor
DK1537113T5 (da) Arylalkylindoler med serotoninreceptoraffinitet anvendelige som terapeutiske midler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DK1517909T3 (da) Tetracykliske arylcarbonylindoler med serotoninreceptor-affinitet til anvendelse som terpaeutiske midler, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger indeholdende dem
WO2025024400A3 (en) Substituted tryptamines and uses thereof
ZA944317B (en) New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them
ECSP972049A (es) Derivados de lactama